Giuseppe Guido Maria Scarlata
Overview
Explore the profile of Giuseppe Guido Maria Scarlata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scarlata G, Abenavoli L
Expert Rev Gastroenterol Hepatol
. 2025 Feb;
19(2):85-88.
PMID: 39907629
No abstract available.
2.
Scarlata G, Ismaiel A, Gambardella M, Leucuta D, Luzza F, Dumitrascu D, et al.
Medicina (Kaunas)
. 2024 Nov;
60(11).
PMID: 39597039
Liver cirrhosis is a chronic, progressive condition characterized by fibrosis and architectural distortion of the liver, leading to impaired liver function and severe complications. Accurately predicting these complications is crucial...
3.
Scarpellini E, Scarcella M, Tack J, Scarlata G, Zanetti M, Abenavoli L
Antioxidants (Basel)
. 2024 Nov;
13(11).
PMID: 39594528
The gut microbiota constitutes a complex microorganism community that harbors bacteria, viruses, fungi, protozoa, and archaea. The human gut bacterial microbiota has been extensively proven to participate in human metabolism,...
4.
Abenavoli L, Spagnuolo R, Scarlata G, Gambardella M, Boccuto L, Mendez-Sanchez N, et al.
Life (Basel)
. 2024 Oct;
14(10).
PMID: 39459526
Background: Inflammatory bowel disease (IBD) is characterized by persistent inflammation and is often associated with metabolic dysfunction-associated steatotic liver disease (MASLD). IBD patients are at risk of developing MASLD due...
5.
Abenavoli L, Imoletti F, Quero G, Bottino V, Facciolo V, Scarlata G, et al.
Diagnostics (Basel)
. 2024 Sep;
14(17).
PMID: 39272629
Superior mesenteric artery (SMA) syndrome or Wilkie's syndrome is a vascular compression disorder that causes the abnormal compression of the third portion of the duodenum by the SMA. It has...
6.
Pavia G, Licata F, Marascio N, Giancotti A, Tassone M, Costa C, et al.
J Infect Public Health
. 2024 Sep;
17(10):102537.
PMID: 39255545
Background: Serodiagnosis of TORCH infections should be performed in pre-pregnancy and reproductive-age women to prevent vertical transmission. Herein, we conducted a 5-year cross-sectional retrospective study in childbearing age women to...
7.
Scarpellini E, Scarlata G, Santori V, Scarcella M, Kobyliak N, Abenavoli L
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200261
Background: Liver cancer, particularly hepatocellular carcinoma (HCC), is a significant gastrointestinal disease with a mortality rate as high as nearly 80% within five years. The disease's pathophysiology involves deranged immune...
8.
Scarlata G, Quirino A, Costache C, Toc D, Marascio N, Pantanella M, et al.
Antibiotics (Basel)
. 2024 Aug;
13(8).
PMID: 39200069
Background: infection (CDI) is a significant cause of mortality, especially in healthcare environments. Reliable biomarkers that can accurately predict mortality in CDI patients are yet to be evaluated. Our study...
9.
Paravati M, Procopio A, Milanovic M, Scarlata G, Milosevic N, Ruzic M, et al.
Nutrients
. 2024 Apr;
16(8).
PMID: 38674916
A sedentary lifestyle associated with unregulated diets rich in high-calorie foods have contributed to the great prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) latterly, with up to 60% in...
10.
Abenavoli L, Gambardella M, Scarlata G, Lenci I, Baiocchi L, Luzza F
Medicina (Kaunas)
. 2024 Apr;
60(4).
PMID: 38674209
The gastrointestinal tract is inhabited by the gut microbiota. The main phyla are Firmicutes and Bacteroidetes. In non-alcoholic fatty liver disease, now renamed metabolic dysfunction-associated fatty liver disease (MAFLD), an...